Todays Report: Today, Forward Pharma A/S (FWP) Given a $44.00 Price Target by Leerink Swann Analysts

Today, Forward Pharma A/S (FWP) Given a $44.00 Price Target by Leerink Swann Analysts

Leerink Swann set a $44.00 price target on Forward Pharma A/S (NASDAQ:FWP) in a research note released on Wednesday morning. The brokerage currently has a buy rating on the stock.

A number of other research analysts also recently weighed in on the company. Zacks Investment Research raised Forward Pharma A/S from a sell rating to a hold rating in a research note on Wednesday, November 2nd. Jefferies Group reissued a buy rating and issued a $40.00 price target on shares of Forward Pharma A/S in a research note on Tuesday, September 27th.

Shares of Forward Pharma A/S (NASDAQ:FWP) opened at 22.32 on Wednesday. Forward Pharma A/S has a 12 month low of $11.22 and a 12 month high of $24.09. The firm’s market cap is $1.05 billion. The firm has a 50 day moving average price of $20.10 and a 200-day moving average price of $19.81.

Hedge funds have recently modified their holdings of the company. Morgan Stanley increased its stake in shares of Forward Pharma A/S by 123.4% in the third quarter. Morgan Stanley now owns 11,078 shares of the company’s stock valued at $233,000 after buying an additional 6,120 shares during the last quarter. Sabby Management LLC increased its stake in shares of Forward Pharma A/S by 33.0% in the second quarter. Sabby Management LLC now owns 102,135 shares of the company’s stock valued at $1,856,000 after buying an additional 25,350 shares during the last quarter. Motley Fool Wealth Management LLC increased its stake in shares of Forward Pharma A/S by 7.1% in the second quarter. Motley Fool Wealth Management LLC now owns 68,760 shares of the company’s stock valued at $1,249,000 after buying an additional 4,529 shares during the last quarter. Perceptive Advisors LLC increased its stake in shares of Forward Pharma A/S by 67.1% in the second quarter. Perceptive Advisors LLC now owns 311,400 shares of the company’s stock valued at $5,658,000 after buying an additional 125,100 shares during the last quarter. Finally, BlueMountain Capital Management LLC increased its stake in shares of Forward Pharma A/S by 21.9% in the first quarter. BlueMountain Capital Management LLC now owns 1,344,495 shares of the company’s stock valued at $22,856,000 after buying an additional 241,571 shares during the last quarter. 22.44% of the stock is currently owned by institutional investors and hedge funds.

Forward Pharma A/S Company Profile

Related posts

Leave a Comment